Analysis of cytokine secretion over 21 d post CAR T cell infusion revealed elevated levels of IFN-gamma and IL-9 at day 7 in the FOLR1 CAR T-treated group bearing OV-90 wt xenografts (Supplementary Figure S7f), which correlated with anti-tumor function. Here, IL9 is linked to neoplasm.